Losses up 86 per cent as Telix launches flagship drug
MELBOURNE: Revenues at cancer fighter Telix Pharmaceuticals have jumped 46 per cent to ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
